These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 16740445
1. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones. Moran G. J Emerg Med; 2006 May; 30(4):377-87. PubMed ID: 16740445 [Abstract] [Full Text] [Related]
2. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA. Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [Abstract] [Full Text] [Related]
3. Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting. Segreti J, House HR, Siegel RE. Am J Med; 2005 Jul; 118 Suppl 7A():21S-28S. PubMed ID: 15993674 [Abstract] [Full Text] [Related]
6. Role of gemifloxacin in community-acquired pneumonia. Tillotson GS. Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107 [Abstract] [Full Text] [Related]
9. Fluoroquinolones in the management of community-acquired pneumonia. Albertson TE, Dean NC, El Solh AA, Gotfried MH, Kaplan C, Niederman MS. Int J Clin Pract; 2010 Feb; 64(3):378-88. PubMed ID: 20456176 [Abstract] [Full Text] [Related]
10. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin. Cantón R, Lode H, Graninger W, Milkovich G. Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S115-27. PubMed ID: 16904873 [Abstract] [Full Text] [Related]
11. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy]. Garin N, Nendaz M. Rev Med Suisse; 2006 Jan 25; 2(50):289-90, 292-4. PubMed ID: 16503046 [Abstract] [Full Text] [Related]
16. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae. Kontou P, Kuti JL, Nicolau DP. Am J Emerg Med; 2009 Oct 25; 27(8):968-74. PubMed ID: 19857416 [Abstract] [Full Text] [Related]
18. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones. Carratalá J, Martín-Herrero JE, Mykietiuk A, García-Rey C. Clin Microbiol Infect; 2006 May 25; 12 Suppl 3():2-11. PubMed ID: 16669924 [Abstract] [Full Text] [Related]
19. [Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults]. Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H. Dtsch Med Wochenschr; 2010 Feb 25; 135(8):359-65. PubMed ID: 20166002 [No Abstract] [Full Text] [Related]